Somnia manages a variety of office-based, ambulatory anesthesia and hospital/inpatient facilities as well as addiction medicine and pain management centers. Addressing one of the fastest growing areas in health care, Somnia is at the forefront of outpatient medical services.
Somnia is recognized by the National Press Club and the Public Relations Society of America as a media expert in the areas of anesthesiology, office-based surgery, pain management and addiction medicine. Several of our affiliated anesthesiologists and experienced personnel have received formal media training and are available for interviews, public speaking engagements, opinions and position statements.
Check out Somnia's new blog here: http://blog.somniaanesthesiaservices.com/
Somnia Has Become a Founding Sponsor for the Hospital Review
The decision to use an anesthesia management company is not easy. It often comes at a time when other options to address administrative needs have been explored and implemented but proven cost-prohibitive or untimely. Depending upon the issues an anesthesia practice is facing and its expectations, desired outcomes may or may not be fully achievable.
by Marc E. Koch from Anesthesia in Cosmetic Surgery
edited by Barry Friedberg © Cambridge University Press 2007.
Reproduced with permission
Centricity poised to help Somnia manage costs, improve workflow and accelerate the revenue cycle for one of the nation’s largest anesthesia practice management companies.
Coalition Board Member Educates FDA on Concerns that Improper Labeling of Fospropofol
Decision on monitored anesthesia care seeks to avoid impact on colon cancer screening rates, provides transition to patient-friendly alternatives in emerging new sedation approaches
by Representative Page (Sponsor) and Schaaf (Co-Sponsor). Read 1st time February 21, 2008 and copies ordered printed. D. Adam Crumbliss, Chief Clerk 5178L.01I
Encourages patients age 50-plus to get regular colon-cancer screenings MINNEAPOLIS (February 6, 2008) – UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company, announced it will continue to provide coverage for the drug propofol, when used as an anesthesia for colonoscopies, and for anesthesiologists to administer the drug during this examination.
by Emily Hagedorn, Californian staff writer